in clinical use, the best-known GIP-related medication is tirzepatide, sold as Mounjaro for type 2 diabetes and Zepbound for weight management, and it is called a dual GIP/GLP-1 receptor agonist because it acts on both pathways
Peptides are short chains of amino acids the same building blocks that make up proteins joined by peptide bonds
[5] Its expansion into tendon, ligament, muscle, and bone research came later, largely from the same group of investigators
ZHX2 knockdown significantly decreased ZHX2 mRNA levels while increasing YTHDF2 mRNA levels (Fig
10.1515/9783110544657-017 117 SensP.GovN
7 In patients with T2DM, the release of incretin hormones is physiologically insufficient, thereby compromising the ability to adequately secrete insulin and also execute other physiologic processes required to meet the metabolic requirements to maintain normoglycemia